The effects of anticancer drugs in combination with nimodipine and verapamil on cultured cells of glioblastoma multiforme

Clinical Neurology and Neurosurgery

Volumn 101, Issue 4, 1999, Pages 238-244

  Durmaz, Ramazan ^a   Deliorman, Selda ^a   Uyar, Ruhi ^a   Işiksoy, Serap ^a   Erol, Kevser ^a   Tel, Eşref ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Anticancer drugs; Culture; Glioblastoma; MTT; Multidrug resistance; Nimodipine

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARMUSTINE; GLYCOPROTEIN P; NIMODIPINE; PROCARBAZINE; VERAPAMIL; VINCRISTINE; VINCRISTINE SULFATE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY;

ANTINEOPLASTIC AGENTS; CALCIUM CHANNEL BLOCKERS; CARMUSTINE; CELL DIVISION; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NIMODIPINE; P-GLYCOPROTEIN; PROCARBAZINE; TUMOR CELLS, CULTURED; VERAPAMIL; VINCRISTINE;

EID: 0032743973     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(99)00061-X     Document Type: Article

References (27)

1. Lum B.L., Gosland M.P., Kaubisch S., Sikic B.I. Molecular targets in oncology: implications of the multidrug resistance gene. Pharmacotherapy. 13:1993;88-109.
2. Fisher G.A., Lum B.L., Hausdorff J., Sikic B.I. Pharmacological considerations in the modulation of multidrug resistance. Eur. J. Cancer. 32A:1996;1082-1088.
3. Tsuruo T., Lida H., Nojiri M., Tsukagoshi S., Sakurai Y. Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res. 43:1983;2905-2910.
4. Tsuruo T., Lida H., Tsukagoshi S., Sakurai Y. Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonist and calmodulin inhibitors. Cancer Res. 43:1983;2267-2272.
5. Robertson R.M., Robertson D. Drugs used for the treatment of myocardial ischemia. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. The Pharmacological Basis of Therapeutics. 1996;759-779 McGraw Hill, New York.
6. Kornblith P.L. Role of tissue culture in prediction of malignancy. Clin. Neurosurg. 25:1978;346-375.
7. Chen T.T., Mealey J. Microculture of human brain tumors. Cancer Chemother. Rep. 54:1970;9-14.
8. Unterman T.G., Glick R.P., Waites G.T., Bell S.C. Production of insulin-like growth factor-binding proteins by human central nervous system tumors. Cancer Res. 51:1991;3030-3036.
9. Freshney R.I. Culture of Animal Cells: A Manual of Basic Technique. 1994;287-300 Wiley-Liss & Sons, Inc, New York.
10. Banker G., Goslin K. Characterizing and studying neuronal cell culture. Banker G., Goslin K. Culturing Nerve Cells. 1991;75-109 The MIT Press, Cambridge.
11. Russell D.S., Rubinstein L.J. Pathology of Tumours of the Nervous System. 1989;133-140 Edward Arnold, London.
12. Kornblith P.L., Szypko P.E. Variations in response of human brain tumors to BCNU in vitro. J. Neurosurg. 48:1978;580-586.
13. Morgan D., Freshney R.I., Darling J.L., Thomas D.G.T., Çelik F. Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma. Br. J. Cancer. 47:1983;205-214.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
15. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601.
16. Motulsky HJ. GraphPad San Diego: GraphPad Software Inc. 1994-1995.
17. Nabors M.W., Griffin C.A., Zehnbauer B.A., Hruban R.H., Phillips P.C., Grossman S.A., Brem H., Colvin O.M. Multidrug resistance gene expression in human brain tumors. J. Neurosurg. 75:1991;941-946.
18. Kornblith P.L., Smith B.H., Leonard L.A. Response of cultured human brain tumors to nitrosoureas: Correlation with clinical data. Cancer. 47:1981;255-265.
19. Jensen R.L., Origitano T.C., Lee Y.S., Weber M., Wurster R.D. In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery. 36:1995;365-373.
20. Shultz P.J., Raij L. Inhibition of human mesangial cell proliferation by calcium channel blockers. Hypertension. 15(Suppl. 2):1990;176-180.
21. Jensen R.L., Lee Y.S., Guijrati M., Origitano T.C., Wurster R.D., Reichman O.H. Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: part II - additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Neurosurgery. 37:1995;937-946.
22. Cordon-Cardo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., Melamed M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38:1990;1277-1287.
23. Tóth K., Vaughan M.M., Peress N.S., Slocum H.K., Rustum M. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am. J. Pathol. 149:1996;853-858.
24. Schinkel A.H., Roelofs E.M., Borst P. Characterization of human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res. 51:1991;2628-2635.
25. Wattel E., Lepelley P., Merlat A., Sartiaux C., Bauters F., Jouet J.P., Fenaux P. Expression of the multidrug resistance P-glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment. Leukemia. 9:1995;1870-1874.
26. Kanerva J., Tiirikainen M., Makipernaa A., Riikonen P., Mottonen M., Salmi T.T., Krusius T., Saarinen-Pihkala U.M. Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL. Pediatr. Hematol. Oncol. 15:1998;11-21.
27. Punyammalee B., Manoromana S., Purisa W., Chariyalertsak S., Rerkamnuaychok B. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer. J. Med. Assoc. Thai. 80(Suppl 1):1997;S162-S173.